Aveanna Healthcare (NASDAQ:AVAH) CEO Jeff Shaner Sells 27,674 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CEO Jeff Shaner sold 27,674 shares of the company’s stock in a transaction dated Wednesday, December 31st. The stock was sold at an average price of $8.18, for a total value of $226,373.32. Following the completion of the transaction, the chief executive officer owned 2,423,536 shares of the company’s stock, valued at $19,824,524.48. The trade was a 1.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Jeff Shaner also recently made the following trade(s):

• On Friday, January 2nd, Jeff Shaner sold 29,357 shares of Aveanna Healthcare stock. The shares were sold at an average price of $7.85, for a total value of $230,452.45.
• On Tuesday, December 30th, Jeff Shaner sold 27,929 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $233,486.44.

Aveanna Healthcare Stock Down 1.1%

Shares of NASDAQ AVAH opened at $8.08 on Friday. The stock has a market capitalization of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The firm’s 50 day simple moving average is $8.92 and its two-hundred day simple moving average is $7.49. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. The firm had revenue of $450.53 million during the quarter. As a group, analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on AVAH. Zacks Research downgraded Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research report on Friday, November 7th. Truist Financial boosted their price objective on Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research report on Friday, November 7th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and increased their price objective for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, William Blair assumed coverage on shares of Aveanna Healthcare in a report on Monday, December 8th. They issued an “outperform” rating on the stock. Five equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $10.69.

Key Headlines Impacting Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Banque Transatlantique SA purchased a new stake in Aveanna Healthcare in the first quarter worth $25,000. Quantbot Technologies LP bought a new position in Aveanna Healthcare in the 2nd quarter worth $43,000. Lion Street Advisors LLC bought a new position in Aveanna Healthcare in the 3rd quarter worth $89,000. Jump Financial LLC purchased a new stake in shares of Aveanna Healthcare in the 1st quarter worth about $59,000. Finally, Diversified Trust Co bought a new stake in shares of Aveanna Healthcare during the 2nd quarter valued at about $57,000. Institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.